MEDICURE INC | CIK:0001133519 | 3

  • Filed: 5/15/2018
  • Entity registrant name: MEDICURE INC (CIK: 0001133519)
  • Generator: Ez-XBRL
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1133519/000127956918001086/0001279569-18-001086-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1133519/000127956918001086/mph-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001133519
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfIncomeTaxExplanatory

    13. Income taxes

     

    The Company recognized a current income tax recovery of $9,392,836 for the year ended December 31, 2017 (2016 – expense of $501,315; 2015 – nil).and a deferred income tax expense of $333,187 for the year ended December 31, 2017 (2016 – recovery of $331,095; 2015 – recovery of $379,000).

     

    As at December 31, 2017 and 2016, deferred tax assets and liabilities have been recognized with respect to the following items:

     

    As at December 31   2017     2016  
    Deferred tax assets                
    Non-capital loss carryforwards   $ 326,108     $ 701,000  
    Total deferred tax assets   $ 326,108     $ 701,000  
                     
    Deferred tax assets/(liabilities)                
    Non-capital loss carryforwards   $ -     $ 1,101,000  
    Research and development credits     -       922,000  
    Intangible assets     -       (38,720,000 )
    Other     -       (1,446,000 )
    Total deferred tax liabilities   $ -     $ (38,143,000 )

     

    As at December 31, 2017 and 2016, deferred tax assets have not been recognized with respect to the following items:

     

    As at December 31   2017     2016  
    Deferred tax assets                
    Non-capital loss carryforwards   $ -     $ 6,449,000  
    Scientific research and experimental development     3,574,000       3,793,000  
    Other     315,000       256,000  
    Total deferred tax assets   $ 3,889,000     $ 10,498,000  

     

    The reconciliation of the Canadian statutory rate to the income tax rate applied to the net income before discontinued operations for the years ended December 31, 2017, 2016 and 2015 to the income tax expense is as follows:

     

    Year ended December 31   2017     2016 - Restated     2015  
    Income (loss) for the year                        
    Canadian   $ (2,178,334 )   $ (4,012,706 )   $ (2,972,573 )
    Foreign     4,615,378       7,807,249       4,262,002  
        $ 2,437,044     $ 3,794,543     $ 1,289,429  

     

    Year ended December 31   2017     2016 - Restated     2015  
    Canadian federal and provincial income taxes at 27% (2016 – 27%; 2015 – 27%)   $ (658,000 )   $ (1,025,000 )   $ (348,000 )
    Permanent differences and other items     (335,000 )     (758,000 )     (537,000 )
    Foreign tax rate in foreign jurisdictions     656,000       2,159,000       652,000  
    Change in unrecognized deferred tax assets     9,397,000     (546,000 )     612,000  
        $ 9,060,000   $ (170,000 )   $ 379,000  

     

    The foreign tax rate differential is the difference between the Canadian federal and provincial statutory income tax rate and the tax rates in Barbados (2.50%), Mauritius (15.00%), Ireland (12.50%), India (33.06%) and the United States (38.00%) that is applicable to income or losses incurred by the Company's subsidiaries.

     

    At December 31, 2017, the Company has the following Barbados losses available for application in future years:

     

    2018   $ 8,366,000  
    2019     2,278,000  
    2020     1,169,000  
    2022     1,231,000  
        $ 13,044,000